No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
LPCN Lipocine
- 4.8700
- +0.1900+4.06%
Close Dec 20 16:00 ET
- 4.7601
- -0.1099-2.26%
Post 19:58 ET
26.04MMarket Cap-6.49P/E (TTM)
5.0000High4.7000Low65.56KVolume4.7000Open4.6800Pre Close318.68KTurnover1.26%Turnover RatioLossP/E (Static)5.35MShares11.790052wk High1.36P/B25.29MFloat Cap2.440352wk Low--Dividend TTM5.19MShs Float1461.9999Historical High--Div YieldTTM6.41%Amplitude2.3100Historical Low4.8600Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Sector Update: Health Care
Lipocine's LPCN 1148 Gets Fast Track Status To Treat Sarcopenia In Decompensated Cirrhosis Patients
Express News | FDA Grants Fast Track Designation to Lipocine for Lpcn 1148 as a Treatment for Sarcopenia in Patients With Decompensated Cirrhosis
FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients With Decompensated Cirrhosis
Express News | Lipocine Announces Publication and Discussion of Lpcn 1148 Manuscript at the Liver Meeting 2024 Editor's Cut Session
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
Heat List
US
Overall
Symbol
Price
% Chg
No Data